CASE REPORT
Histoplasmosis Endophthalmitis – Case Report and Review
Christopher J. Parronchi1, *, Vatsal Doshi2, Ronald G. Nahass1, 3
Article Information
Identifiers and Pagination:
Year: 2018Volume: 10
First Page: 71
Last Page: 75
Publisher Id: TOIDJ-10-71
DOI: 10.2174/1874279301810010071
Article History:
Received Date: 17/03/2018Revision Received Date: 31/05/2018
Acceptance Date: 08/6/2018
Electronic publication date: 29/06/2018
Collection year: 2018
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Introduction:
Histoplasma Capsulatum (HC) is one of the most common endemic mycoses in the United States of America, and has also been reported in large numbers in various regions of Central and South America. It can cause disease ranging in severity from an upper respiratory tract-like infection, to deep single organ disease and most concerning, widely disseminated disease resulting in harmful sequelae. Presumed Ocular Histoplasmosis Syndrome (POHS) is the most common ocular manifestation of histoplasmosis and usually results in permanent disability.
Discussion and Conclusion:
In this study, we describe a rarely reported case of histoplasmosis endophthalmitis that was treated with itraconazole and resulted in almost complete resolution of all retinal findings and symptoms.